These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16046313)

  • 41. Effect of salsalate on insulin action, secretion, and clearance in nondiabetic, insulin-resistant individuals: a randomized, placebo-controlled study.
    Kim SH; Liu A; Ariel D; Abbasi F; Lamendola C; Grove K; Tomasso V; Ochoa H; Reaven G
    Diabetes Care; 2014 Jul; 37(7):1944-50. PubMed ID: 24963111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oscillations in insulin secretion during constant glucose infusion in normal man: relationship to changes in plasma glucose.
    Shapiro ET; Tillil H; Polonsky KS; Fang VS; Rubenstein AH; Van Cauter E
    J Clin Endocrinol Metab; 1988 Aug; 67(2):307-14. PubMed ID: 3292558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for a potent antiinflammatory effect of rosiglitazone.
    Mohanty P; Aljada A; Ghanim H; Hofmeyer D; Tripathy D; Syed T; Al-Haddad W; Dhindsa S; Dandona P
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2728-35. PubMed ID: 15181049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue.
    Mai K; Andres J; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):419-25. PubMed ID: 17555498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance.
    Ehrmann DA; Breda E; Cavaghan MK; Bajramovic S; Imperial J; Toffolo G; Cobelli C; Polonsky KS
    Diabetologia; 2002 Apr; 45(4):509-17. PubMed ID: 12032626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.
    Mari A
    Diabetologia; 1998 Sep; 41(9):1029-39. PubMed ID: 9754821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
    Beeson M; Sajan MP; Dizon M; Grebenev D; Gomez-Daspet J; Miura A; Kanoh Y; Powe J; Bandyopadhyay G; Standaert ML; Farese RV
    Diabetes; 2003 Aug; 52(8):1926-34. PubMed ID: 12882907
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects.
    James AP; Watts GF; Mamo JC
    Diabetes Obes Metab; 2005 Jul; 7(4):381-9. PubMed ID: 15955124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperinsulinemia in offspring of non-insulin-dependent diabetes mellitus patients: the role played by abnormal clearance of insulin.
    Cozzolino D; Sessa G; Salvatore T; Sasso FC; Giugliano D; Torella R
    Metabolism; 1995 Oct; 44(10):1278-82. PubMed ID: 7476284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test.
    Retnakaran R; Shen S; Hanley AJ; Vuksan V; Hamilton JK; Zinman B
    Obesity (Silver Spring); 2008 Aug; 16(8):1901-7. PubMed ID: 18551118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog.
    Polonsky KS; Pugh W; Jaspan JB; Cohen DM; Karrison T; Tager HS; Rubenstein AH
    J Clin Invest; 1984 Nov; 74(5):1821-9. PubMed ID: 6389599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of rosiglitazone treatment on beta-cell function in type 2 diabetes: evidence of an increased ability of glucose to entrain high-frequency insulin pulsatility.
    Juhl CB; Hollingdal M; Pørksen N; Prange A; Lönnqvist F; Schmitz O
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3794-800. PubMed ID: 12915671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma leptin concentrations do not appear to decrease insulin-mediated glucose disposal or glucose-stimulated insulin secretion in women with normal glucose tolerance.
    Carantoni M; Abbasi F; Azhar S; Chen YD; Klebanov M; Wang PW; Warmerdam F; Reaven GM
    Diabetes; 1998 Feb; 47(2):244-7. PubMed ID: 9519720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
    Oakes ND; Thalén PG; Jacinto SM; Ljung B
    Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.
    Rosenfalck AM; Maghsoudi S; Fisker S; Jørgensen JO; Christiansen JS; Hilsted J; Vølund AA; Madsbad S
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4173-81. PubMed ID: 11095450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.
    Carpentier A; Mittelman SD; Bergman RN; Giacca A; Lewis GF
    Diabetes; 2000 Mar; 49(3):399-408. PubMed ID: 10868961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sequential infusions of glucose and insulin at prefixed rates: a simple method for assessing insulin sensitivity and insulin responsiveness.
    Heine RJ; Bilo HJ; van der Meer J; van der Veen EA
    Diabetes Res; 1986 Nov; 3(9):453-61. PubMed ID: 3549121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Estimation of insulin secretion rate in multiple sampled intravenous glucose tolerance test].
    Ran J; Cheng H; Li F; Liu S; Xiao H; Chen M; Huang X
    Zhonghua Nei Ke Za Zhi; 2001 Feb; 40(2):89-92. PubMed ID: 11798560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.